Venture into the labyrinth of investment opportunities as we uncover the top momentum stocks making waves in the market on this auspicious day of March 12th:
Li Auto Inc. LI: Standing out as a beacon of potential, this China-based new energy vehicles company boasts a Zacks Rank #1. In a testament to its strength, the Zacks Consensus Estimate for its current year earnings has surged impressively by 6.7% within the last 60 days.
Li Auto Inc. Bolsters Momentum Scores
Li Auto has been a shining star, with its shares witnessing a commendable 22.1% growth over the past month, eclipsing the S&P 500’s modest 3% advance. Garnering a coveted Momentum Score of A, the company is navigating the market with finesse.
Sumitomo Mitsui Financial Group Inc: Resilience Personified
Enter Sumitomo Mitsui Financial Group Inc, a titan providing a myriad of financial services. With a Zacks Rank #1, the company’s Zacks Consensus Estimate for current year earnings surged by an impressive 9.3% in the last 60 days.
Sumitomo Mitsui Financial Group Inc: Sailing Smoothly
Sumitomo Mitsui’s shares have seen a robust growth of 17.2% over the last three months, overshadowing the S&P 500’s 8.4% rise. Boasting a Momentum Score of A, the company stands strong in the volatile market.
Korn Ferry: The Beacon of Consulting Services
Lastly, Korn Ferry, a stalwart in the consulting services sector, proudly flaunts a Zacks Rank #1. The Zacks Consensus Estimate for its current year earnings saw a notable upswing of 6.1% in the past 60 days.
Korn Ferry: Setting the Bar High
Korn Ferry’s stock has shown resilience, surging by 14.8% over the last three months, outperforming the S&P 500’s growth trajectory of 8.4%. With a Momentum Score of A, Korn Ferry remains a force to be reckoned with in the market.
Peek into the realm of top-ranked stocks here and acquaint yourself with the dynamics of the market using the Momentum score.
Curious about Zacks’ “Single Best Pick to Double”?
Behold the promise of exponential growth! Amidst a whirlwind of stocks, Zacks experts have flagged a remarkable contender poised to surge by +100% or more in the foreseeable future. Director of Research Sheraz Mian has handpicked this gem, lauded for a groundbreaking medical discovery. With a flourishing pipeline of transformative projects, it stands at the cusp of revamping the landscape for patients grappling with liver, lung, and blood-related ailments. Seize this opportunity amidst a sea of bear market lows, a prospect akin to the meteoric rise of past stalwarts like Boston Beer Company (+143.0% in just over 9 months) and NVIDIA (+175.9% in a year).